| (210) | Number of the EPO application | 18759491 |
| (220) | Filing date of the EPO application | 2018.08.06 |
| (80) | EPO patent specification publication (B) | EPB nr. 14/2024, 2024.04.03 |
| (110) | EPO patent number | 3661945 |
| (21) | Number of the application | e 2020 0617 |
| (71) | Name(s) of applicant(s), code of the country | Ardelyx, Inc., US; |
| (72) | Name(s) of inventor(s), code of the country | LUEHR Gary, US;
DRAGOLI Dean, US;
LEADBETTER Michael, US;
CHEN Tao, US;
LEWIS Jason, US; |
| (73) | Name(s) of owner(s), code of the country | Ardelyx, Inc., US; |
| (54) | Title of the invention | GLYCYRRHETINIC ACID DERIVATIVES FOR TREATING HYPERKALEMIA |
| (13) | Kind-of-document code | A1 |
| (51) | International Patent Classification | C07J 63/00 (2006.01.01); A61K 31/575 (2006.01.01); A61P 5/44 (2006.01.01) |
| (19) | Country | US |
| (41) | Date of publication of the application | 2020.06.30 |
| (30) | Priority | 201762541095 P, 2017.08.04, US |
| (86) | International application | PCT/US2018/045421, 2018.08.06 |
| (87) | International publication | WO 2019/060051, 2019.03.28 |